This work was supported by grants from the Academic Research Fund of the Ministry of Education, and the National Medical Research Council and the National Research Foundation, Singapore.

Aのバイオフィルム形成の1クリスタルバイオレット定量バウマニ S1 <ol><li> A. 5mlの文化を育て振盪インキュベーター（220 rpm）し、30℃でのLB培地（LB）（トリプトンを10g / L、酵母エキス5グラム/ L）でバウマニ S1 16時間。 </li><li> A.の文化を調整バウマニ S1 0.8の所望のOD 600まで。 96ウェルプレートを使用して、細菌培養物接種：精製GKL酵素（40 mg / mlで）の10μLを含有する新鮮なLBに（1 100希釈）。新しい文化の最終容量は100μlです。 </li><li>同様に対照培養物を準備し;これは、任意の酵素が含まれません。複製の所望の数を得るために同様の条件を繰り返します。 </li><li>蓋付きプレートを覆い、密封された10リットルのプラスチック容器に入れてください。優しくメディアを削除する前に、3時間、30℃でプレートをインキュベートします。 </li><li>新鮮なLB培地の別の100μlをウェルに加え、30℃で21時間静置します。 </li&gt; <li>インキュベーションの第二の期間の後、静かにすべてのメディアを削除します。 200μlの滅菌水でプランクトン細菌細胞を洗浄します。洗浄中の細胞にのみ最小限の乱れがあることを確認します。 </li><li>各ウェルに1％クリスタルバイオレット溶液100μlを加え、室温で15分間インキュベートします。 200μlの滅菌水でよく洗浄することにより、クリスタルバイオレット溶液を除去します。さらに2回の洗浄を繰り返します。 </li><li>各ウェルに33％酢酸を100μl加え、穏やかに振盪しながら15分間インキュベートします。これは、色素を溶解します。 </li><li> 600nmにおけるクリスタルバイオレットの吸光度を測定することによって形成されたバイオフィルムの量を定量します。クリスタルバイオレットの量は、形成されたバイオフィルムの量に比例します。 </li></ol> A. 2.共焦点レーザー走査顕微鏡バウマニ S1バイオフィルム<ol><li> A. 5mlの文化を育て16時間振とう培養（220 rpm）し、30℃でのLBでバウマニ S1。 </li><li>広告A.だけの文化バウマニ S1 0.8の所望のOD 600まで。 35mmのガラス底のμ-皿を使用して、細菌培養の接種：精製されたGKL酵素（40 mg / mlの）の30μLを含む新鮮なLBに（1 100希釈）;新しい文化の最終容量を1 mlです。 </li><li>蓋付きのμ-皿を覆い、密封された10リットルのプラスチック容器に入れてください。優しくメディアを削除する前に、3時間30℃でμ-皿をインキュベートします。 1ミリリットルの全容量にそれをもたらし、精製GKL酵素と新鮮な培地30μlのを追加します。 30℃でさらに21時間インキュベートします。 </li><li>繰り返しステップ2.3および30℃でさらに24時間μ-皿をインキュベートします。そして、そっとメディアを削除します。 </li><li> μ-皿にハンクス平衡塩溶液（HBSS）中に溶解し5μg/ mlのアレックスのFluo 488結合小麦胚芽凝集素（WGA）の500μLを加え、37℃で30分間インキュベートし;これは、形成されたバイオフィルムを染色します。 T染色溶液を除去し、洗浄彼はHBSS 2mlで皿をμ。洗浄ステップをもう一度繰り返します。 </li><li> HBSSに溶解した3.7％ホルムアルデヒド500μlのを追加し、37℃で30分間インキュベートし;これは、μ-皿にバイオフィルムを修正します。 HBSS 2mlで一度μ-皿を洗い、その後、完全に溶液を除去。 μ皿バイオフィルムで固定前CLSM画像に4℃で暗所に保存することができます。 </li><li> CLSMイメージングおよび分析のために、スタックあたり0.21ミクロンの間隔で画像あたり97スタックを生成するために、63倍の倍率を使用しています。 </li></ol>

<ol>
	<li>Alanis, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Resistance+to+antibiotics:+are+we+in+the+post-antibiotic+era?.">Resistance to antibiotics: are we in the post-antibiotic era?.</a> Archives of medical research. 36, 697-705 (2005).</li><li>Cegelski, L., Marshall, G. R., Eldridge, G. R., Hultgren, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+biology+and+future+prospects+of+antivirulence+therapies.">The biology and future prospects of antivirulence therapies.</a> Nature reviews. Microbiology. 6, 17-27 (2008).</li><li>LaSarre, B., Federle, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Exploiting+quorum+sensing+to+confuse+bacterial+pathogens.">Exploiting quorum sensing to confuse bacterial pathogens.</a> Microbiology and molecular biology reviews : MMBR. 77, 73-111 (2013).</li><li>Waters, C. M., Bassler, B. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quorum+sensing:+cell-to-cell+communication+in+bacteria.">Quorum sensing: cell-to-cell communication in bacteria.</a> Annual Review of Cell and Developmental Biology. 21, 319-346 (2005).</li><li>Rasko, D. A., Sperandio, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Anti-virulence+strategies+to+combat+bacteria-mediated+disease.">Anti-virulence strategies to combat bacteria-mediated disease.</a> Nature reviews. Drug discovery. 9, 117-128 (2010).</li><li>Lazar, V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Quorum+sensing+in+biofilms--how+to+destroy+the+bacterial+citadels+or+their+cohesion/power?.">Quorum sensing in biofilms--how to destroy the bacterial citadels or their cohesion/power?.</a> Anaerobe. 17, 280-285 (2011).</li><li>Costerton, J. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bacterial+Biofilms:+A+Common+Cause+of+Persistent+Infections.">Bacterial Biofilms: A Common Cause of Persistent Infections.</a> Science. 284, 1318-1322 (1999).</li><li>Perez, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Global+challenge+of+multidrug-resistant+Acinetobacter+baumannii.">Global challenge of multidrug-resistant Acinetobacter baumannii.</a> Antimicrob Agents Chemother. 51, 3471-3484 (2007).</li><li>Tay, S. B., Yew, W. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+of+quorum-based+anti-virulence+therapeutics+targeting+Gram-negative+bacterial+pathogens.">Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.</a> International journal of molecular sciences. 14, 16570-16599 (2013).</li><li>Igarashi, J., Suga, H., Rumbaugh, K. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ch.+19.">Ch. 19.</a> Quorum Sensing. 692, 265-274 (2011).</li><li>Ng, F. S., Wright, D. M., Seah, S. Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characterization+of+a+phosphotriesterase-like+lactonase+from+Sulfolobus+solfataricus+and+its+immobilization+for+disruption+of+quorum+sensing.">Characterization of a phosphotriesterase-like lactonase from Sulfolobus solfataricus and its immobilization for disruption of quorum sensing.</a> Applied and environmental microbiology. 77, 1181-1186 (2011).</li><li>Stacy, D. M., Welsh, M. A., Rather, P. N., Blackwell, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Attenuation+of+quorum+sensing+in+the+pathogen+Acinetobacter+baumannii+using+non-native+N-Acyl+homoserine+lactones.">Attenuation of quorum sensing in the pathogen Acinetobacter baumannii using non-native N-Acyl homoserine lactones.</a> ACS chemical biology. 7, 1719-1728 (2012).</li><li>Chow, J. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Directed+evolution+of+a+thermostable+quorum-quenching+lactonase+from+the+amidohydrolase+superfamily.">Directed evolution of a thermostable quorum-quenching lactonase from the amidohydrolase superfamily.</a> The Journal of biological chemistry. 285, 40911-40920 (2010).</li><li>Chow, J. Y., Yang, Y., Tay, S. B., Chua, K. L., Yew, W. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Disruption+of+biofilm+formation+by+the+human+pathogen+Acinetobacter+baumannii+using+engineered+quorum-quenching+lactonases.">Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases.</a> Antimicrobial Agents and Chemotherapy. 58, 1802-1805 (2014).</li><li>Pour, N. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biofilm+formation+by+Acinetobacter+baumannii+strains+isolated+from+urinary+tract+infection+and+urinary+catheters.">Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters.</a> FEMS immunology and medical microbiology. 62, 328-338 (2011).</li></ol>

The authors declare that they have no competing financial interests.

実験の両方のセットは、A.バウマンニ S1は、高い塩濃度とのNaClなしLB培地で培養したバクテリア15によって形成されたバイオフィルムの量を減少させることができます。このようなアーティファクトの存在は、バイオフィルム形成量、ならびに異なる処理条件全体の定足数消光酵素の影響を過小評価する可能性があります。触媒的に不活性な酵素の使用は、酵素隔離の影響の可?...

感染症の治療の選択肢は、抗生物質1の広い範囲に影響されない多剤耐性菌の急速な増加によって複雑にされています。耐性細菌媒介性感染症からの高い罹患率および死亡率と、薬物開発プロセスをエスカレートおよび/または治療選択肢を改善するための優れた抗菌選択肢を探索する必要があります。最近では、抗病原性のアプローチは、したがって耐性機構2のリスクを軽減する、非殺菌方法を介して病原性を防止する上で、その潜在的な特定の関心を集めています。 クオラムセンシングは、このシグナリング現象の細菌の病原性と混乱の「マスタースイッチが「病因3に対する有望な抗病原性の方法です。重要な細菌の人口密度に達した後毒性の発症は細胞外環境における定足数の分子の蓄積が必要です。現状として、ラム酒の分子は、その同族受容体との結合は病原性因子だけでなく、抗生物質耐性およびバイオフィルム形成を4に関連する遺伝子の活性化につながる、細胞内マトリックスに戻って拡散します。一般的には、クオラムセンシング破壊が主要代謝経路に影響を与えることなく、定足数分子と受容体の相互作用を阻害することを含みます。したがって、細胞の成長に直接的な意味合いを持っていません。適応度が損なわれないので、進化し、そのような治療5に対する耐性を得るために、細菌のための最小限の選択圧があります。また、クオラムセンシングの破壊は、抗細菌剤からの保護を提供し、免疫応答をホストしてバイオフィルム形成の場合のように、固有の細菌の防御機構を妨害することができます。 それは、地球上の微生物の99％は目の中に生きた微生物に重要な生存の利点を付与する、複雑なバイオフィルムのようなマトリックス中に存在することが推定されていますESEの構造6。さらに重要なことは、これらの固着ドメインの形成は、最も永続的なおよび慢性院内感染7の原因である。 アシネトバクターバウマニは、グローバルな院内感染に関連付けられており、その毒性が大きくクオラムセンシングに起因する主要なヒト病原体の一つであります媒介バイオフィルム形成8。クォーラム消光酵素は、グラム陰性菌9によって生成されたN -アシルホモセリンラクトン（AHLs）として知られている化合物群をターゲットにして、クォーラムが介在するシグナル伝達を妨害するで正常に使用されています。いくつかの研究はまた、バイオフィルム10,11における毒性因子の発現および細胞数の削減による細菌の病原性を遮断するために、これらの酵素の使用に拡大しています。残念ながら、細菌性病原体によるバイオフィルム形成に対する定足数消光酵素の有効利用の触知可能なデモの欠如が残っています。ザ・再A.を破壊し 、定足数阻害剤（AHL類似体）、代わりの定足数消光酵素を使用する試みてきましたバウマニバイオフィルム形成12。小分子阻害剤を使用して、この方法が有効なアプローチであるが、翻訳の用途におけるその生物学的利用能を維持することが課題であることができます。酵素は治療効果のための生物医学装置の表面上に固定化に対してより敏感に反応するように逆に、触媒定​​足数消光酵素の使用は、生物学的利用能の問題を回避することができます。 ここでは、クリスタルバイオレット染色および共焦点レーザー走査顕微鏡（CLSM）を用いて、細菌のバイオフィルム形成に13（GKL） ゲオバチルスのkaustophilusから操作さクオラムクエンチングラクトナーゼの効果の評価を説明します。この研究は、臨床的に関連するAのバイオフィルム破壊の最初に成功した実証であります定足数消光酵素を用いバウマニ S1株。方法が記載さこの研究において、病原性グラム陰性菌に対する後続の治療の開発努力の他のクオラムクエンチング酵素の有効性を評価するために有用です。

<table><tbody><tr><td>Tryptone&amp;nbsp;</td><td>BD</td><td>211705</td><td></td></tr><tr><td>Yeast Extract</td><td>BD</td><td>212750</td><td></td></tr><tr><td>96-well plate</td><td>Costar</td><td>3596</td><td></td></tr><tr><td>Crystal Violet</td><td>Sigma-Aldrich</td><td>C6158</td><td></td></tr><tr><td>Acetic Acid</td><td>Lab-Scan</td><td>PLA00654X</td><td>Caution: Flammable</td></tr><tr><td>&amp;mu;-Dish</td><td>Ibidi</td><td>80136</td><td></td></tr><tr><td>Alex Fluo 488-conjugated WGA</td><td>Invitrogen</td><td>W11261</td><td></td></tr><tr><td>Hank&amp;rsquo;s balanced salt solution&amp;nbsp;</td><td>Invitrogen</td><td>141475095</td><td></td></tr><tr><td>Formaldehyde</td><td>Sigma-Aldrich</td><td>F8775</td><td>Caution: Corrosive&amp;nbsp;</td></tr><tr><td>Synergy HT Microplate Reader</td><td>BioTek</td><td></td><td></td></tr><tr><td>1X-81 Inverted Fluorescence Microscope</td><td>Olympus</td><td></td><td></td></tr></tbody></table>

anti-virulent disruption of pathogenic biofilms using engineered quorum-quenching lactonases

The rapid emergence of multi-drug resistant bacteria has accelerated the need for novel therapeutic approaches to counter life-threatening infections. The persistence of bacterial infection is often associated with quorum-sensing-mediated biofilm formation. Thus, the disruption of this signaling circuit presents an attractive anti-virulence strategy. Quorum-quenching lactonases have been reported to be effective disrupters of quorum-sensing circuits. However, there have been very few reports of the effective use of these enzymes in disrupting bacterial biofilm formation. This protocol describes a method to disrupt biofilm formation in a clinically relevant A. baumannii S1 strain through the use of an engineered quorum-quenching lactonase. Acinetobacter baumannii is a major human pathogen implicated in serious hospital-acquired infections globally and its virulence is attributed predominantly to its biofilm's tenacity. The engineered lactonase treatment achieved significant A. baumannii S1 biofilm reduction. This study also showed the possibility of using engineered quorum-quenching enzymes in future treatment of biofilm-mediated bacterial diseases. Lastly, the method may be used to evaluate the competency of promising quorum-quenching enzymes.

クリスタルバイオレット定量実験では、2つの定足数消光酵素がバイオフィルム形成を破壊で実行可能性を実証するために使用した：野生型GKLおよび改善GKL二重変​​異（E101G / R230C）。両酵素は、3-ヒドロキシデカノイル- L -ホモセリンラクトン（3-OH-C 10 -HSL）、A.で使用される主要な定足数分子に対するラクトナーゼ活性を示すことが示されています...

Watch this Scientific Journal Video about Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases at JoVE.com

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Quorum-quenching enzymes are anti-virulent and anti-bacterial options that can mitigate pathogenesis without risk of incurring resistance, by preventing the expression of virulence factors and genes associated with antibiotic resistance and biofilm formation. In this study, we report a method that demonstrates the efficacy of quorum-quenching enzymes in bacterial biofilm disruption.

エンジニアクォーラム焼入れラクトナーゼを使用して、病原性バイオフィルムの抗病原性破壊

The rapid emergence of multi-drug resistant bacteria has accelerated the need for novel therapeutic approaches to counter life-threatening infections. The ...

anti-virulent-disruption-pathogenic-biofilms-using-engineered-quorum

Research

JoVE Journal

Immunology and Infection

10.6K ビュー.  Yong Loo Lin School of Medicine. Quorum-quenching enzymes are anti-virulent and anti-bacterial options that can mitigate pathogenesis without risk of incurring resistance, by preventing the expression of virulence factors and genes associated with antibiotic resistance and biofilm formation. In this study, we report a method that demonstrates the efficacy of quorum-quenching enzymes in bacterial biofilm disruption.

ビデオ: Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Microtiter Dish Biofilm Formation Assay

Biofilms are communities of microbes attached to surfaces, which can be found in medical, industrial and natural settings. In fact, life in a biofilm probably represents the predominate mode of growth for microbes in most environments. Mature biofilms have a few distinct characteristics. Biofilm microbes are typically surrounded by an extracellular matrix that provides structure and protection to the community. Microbes growing in a biofilm also have a characteristic architecture generally comprised of macrocolonies (containing thousands of cells) surrounded by fluid-filled channels. Biofilm-grown microbes are also notorious for their resistance to a range of antimicrobial agents including clinically relevant antibiotics.
The microtiter dish assay is an important tool for the study of the early stages in biofilm formation, and has been applied primarily for the study of bacterial biofilms, although this assay has also been used to study fungal biofilm formation. Because this assay uses static, batch-growth conditions, it does not allow for the formation of the mature biofilms typically associated with flow cell systems. However, the assay has been effective at identifying many factors required for initiation of biofilm formation (i.e, flagella, pili, adhesins, enzymes involved in cyclic-di-GMP binding and metabolism) and well as genes involved in extracellular polysaccharide production. Furthermore, published work indicates that biofilms grown in microtiter dishes do develop some properties of mature biofilms, such a antibiotic tolerance and resistance to immune system effectors.
This simple microtiter dish assay allows for the formation of a biofilm on the wall and/or bottom of a microtiter dish. The high throughput nature of the assay makes it useful for genetic screens, as well as testing biofilm formation by multiple strains under various growth conditions. Variants of this assay have been used to assess early biofilm formation for a wide variety of microbes, including but not limited to, pseudomonads, Vibrio cholerae, Escherichia coli, staphylocci, enterococci, mycobacteria and fungi.
In the protocol described here, we will focus on the use of this assay to study biofilm formation by the model organism Pseudomonas aeruginosa. In this assay, the extent of biofilm formation is measured using the dye crystal violet (CV). However, a number of other colorimetric and metabolic stains have been reported for the quantification of biofilm formation using the microtiter plate assay. The ease, low cost and flexibility of the microtiter plate assay has made it a critical tool for the study of biofilms.

The assay describes a rapid means to measure early biofilm formation in bacteria and fungi. This method uses a microtiter plate as the substratum for microbial biofilm formation, and the biofilm is visualized using crystal violet strain. The assay provides either a qualitative or quantitative assay for early biofilm formation.

マイクロタイター皿のバイオフィルム形成アッセイ

Biofilms are communities of microbes attached to surfaces, which can be found in medical, industrial and natural settings.  In fact, life in a biofilm ...

免疫・感染学

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

The method described here consists in redesigning E. coli adherence properties by assembling the minimum number of curli genes under the control of a strong and metal-overinducible promoter, and in visualizing and quantifying the resulting gain of bacterial adherence. This method applies appropriate engineering principles of abstraction and standardization of synthetic biology, and results in the BBa_K540000 Biobrick (Best new Biobrick device, engineered, iGEM 2011).
The first step consists in the design of the synthetic operon devoted to curli overproduction in response to metal, and therefore in increasing the adherence abilities of the wild type strain. The original curli operon was modified in silico in order to optimize transcriptional and translational signals and escape the "natural" regulation of curli. This approach allowed to test with success our current understanding of curli production. Moreover, simplifying the curli regulation by switching the endogenous complex promoter (more than 10 transcriptional regulators identified) to a simple metal-regulated promoter makes adherence much easier to control.
The second step includes qualitative and quantitative assessment of adherence abilities by implementation of simple methods. These methods are applicable to a large range of adherent bacteria regardless of biological structures involved in biofilm formation. Adherence test in 24-well polystyrene plates provides a quick preliminary visualization of the bacterial biofilm after crystal violet staining. This qualitative test can be sharpened by the quantification of the percentage of adherence. Such a method is very simple but more accurate than only crystal violet staining as described previously 1 with both a good repeatability and reproducibility. Visualization of GFP-tagged bacteria on glass slides by fluorescence or laser confocal microscopy allows to strengthen the results obtained with the 24-well plate test by direct observation of the phenomenon.

The design of a synthetic operon encoding both the secretory apparatus and the structural monomers of curli fibers is described. Overproduction of these amyloids and adherent polymers allows a measurable gain of adherence of the E. coli chassis1. Easy ways to visualize and quantify adherence are explained.

単一の合成Curliオペロンを作成して付着細菌を工学

The  method described here consists in redesigning E. coli adherence properties by assembling the minimum number of  curli genes under the control of a ...

生物工学

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Most pathogenic bacteria are able to form biofilms during infection, but due to the difficulty of manipulating and assessing biofilms, the vast majority of laboratory work is conducted with planktonic cells. Here, we describe a peg plate biofilm assay as performed with Staphylococcus aureus. Bacterial biofilms are grown on pegs attached to a 96-well microtiter plate lid, washed through gentle submersion in buffer, and placed in a drug challenge plate. After subsequent incubation they are again washed and moved to a final recovery plate, in which the fluorescent dye resazurin serves as a viability indicator. This assay offers greatly increased ease-of-use, reliability, and reproducibility, as well as a wealth of data when conducted as a kinetic read. Moreover, this assay can be adapted to a medium-throughput drug screening approach by which an endpoint fluorescent readout is taken instead, offering a path for drug discovery efforts.

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Most bacterial infections produce a biofilm. By virtue of their environment, biofilm associated bacteria are often phenotypically drug resistant. Novel antibacterial molecules that kill bacteria in biofilms are thus a high priority. We establish an assay to quickly screen for antimicrobial compounds that are effective at eradicating biofilms.

バイオフィルム関連をターゲット<em&gt;黄色ブドウ球菌</em&gt;レサズリン基づく薬剤感受性アッセイを使用して

Most pathogenic bacteria are able to form biofilms during infection, but due to the difficulty of manipulating and assessing biofilms, the vast majority ...

Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors

This work assesses different methodologies to study the impact of small molecule biofilm inhibitors, such as D-amino acids, on the development and resilience of Bacillus subtilis biofilms. First, methods are presented that select for small molecule inhibitors with biofilm-specific targets in order to separate the effect of the small molecule inhibitors on planktonic growth from their effect on biofilm formation. Next, we focus on how inoculation conditions affect the sensitivity of multicellular, floating B. subtilis cultures to small molecule inhibitors. The results suggest that discrepancies in the reported effects of such inhibitors such as D-amino acids are due to inconsistent pre-culture conditions. Furthermore, a recently developed protocol is described for evaluating the contribution of small molecule treatments towards biofilm resistance to antibacterial substances. Lastly, scanning electron microscopy (SEM) techniques are presented to analyze the three-dimensional spatial arrangement of cells and their surrounding extracellular matrix in a B. subtilis biofilm. SEM facilitates insight into the three-dimensional biofilm architecture and the matrix texture. A combination of the methods described here can greatly assist the study of biofilm development in the presence and absence of biofilm inhibitors, and shed light on the mechanism of action of these inhibitors.

Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors

This study presents the development of reproducible methodologies to study biofilm inhibitors and their effects on Bacillus subtilis multicellularity.

研究のための方法論<em&gt; B。枯草菌</em小分子バイオフィルム阻害剤を特徴付けるためのモデルとしての&gt;バイオフィルム

This work assesses different methodologies to study the impact of small molecule biofilm inhibitors, such as D-amino acids, on the development and ...

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Biofilms are regarded as one of the most challenging topics of modern biomedicine, and they are potentially responsible for over 80% of antibiotic-tolerant infections. Biofilms have displayed an exceptionally high tolerance for chemotherapy, which is thought to be multifactorial. For instance, the matrix provides a physical barrier that decreases the penetration of antibiotics into the biofilm. Also, cells within the biofilms are phenotypically diverse. Likely, biofilm resilience arises from a combination of these and other, yet unknown, mechanisms. All of the currently existing antibiotics have been developed against single-cells (planktonic) bacteria. Therefore, so far, a very limited repertoire of molecules exists that can selectively act on mature biofilms. This situation has driven a progressive paradigm shift in drug discovery, in which searching for anti-biofilms has been urged to occupy a more prominent place. An additional challenge is that there are a very limited number of standardized methods for biofilm research, especially those that can be used for large-throughput screening of chemical libraries. Here, an experimental anti-biofilm platform for chemical screening is presented. It uses three assays to measure biofilm viability (with resazurin staining), total biomass (with crystal violet staining), and biofilm matrix (using a wheat germ agglutinin, WGA-fluorescence-based staining of the poly-N-acetyl-glucosamine, PNAG, fraction). All the assays were developed using Staphylococcus aureus as the model bacteria. Examples of how the platform can be used for primary screening as well as for functional characterization of identified anti-biofilm hits are presented. This experimental sequence further allows for the classification of the hits based upon the measured end-points. It also provides information on their mode of action, especially on long-term versus short-term chemotherapeutic effects. Thus, it is very advantageous for the quick identification of high-quality hit compounds that can serve as starting points for various biomedical applications.

Biofilm infections show high tolerance towards chemotherapy. No single assay captures the complexity of biofilms. Instead, complementary assays are needed. We present a screening platform (developed for S. aureus) that combines assays for viability, biomass, and biofilm matrix. It allows anti-biofilm drug discovery, including the assessment of long-term chemotherapeutic effects.

天然化合物ライブラリーの探査に適した抗バイオフィルムアッセイのプラットフォーム

Biofilms are regarded as one of the most challenging topics of modern biomedicine, and they are potentially responsible for over 80% of ...

Use of the Soft-agar Overlay Technique to Screen for Bacterially Produced Inhibitory Compounds

The soft-agar overlay technique was originally developed over 70 years ago and has been widely used in several areas of microbiological research, including work with bacteriophages and bacteriocins, proteinaceous antibacterial agents. This approach is relatively inexpensive, with minimal resource requirements. This technique consists of spotting supernatant from a donor strain (potentially harboring a toxic compound(s)) onto a solidified soft agar overlay that is seeded with a bacterial test strain (potentially sensitive to the toxic compound(s)). We utilized this technique to screen a library of Pseudomonas syringae strains for intraspecific killing. By combining this approach with a precipitation step and targeted gene deletions, multiple toxic compounds produced by the same strain can be differentiated. The two antagonistic agents commonly recovered using this technique are bacteriophages and bacteriocins. These two agents can be differentiated using two simple additional tests. Performing a serial dilution on a supernatant containing bacteriophage will result in individual plaques becoming less in number with greater dilution, whereas serial dilution of a supernatant containing bacteriocin will result a clearing zone that becomes uniformly more turbid with greater dilution. Additionally, a bacteriophage will produce a clearing zone when spotted onto a fresh soft agar overlay seeded with the same strain, whereas a bacteriocin will not produce a clearing zone when transferred to a fresh soft agar lawn, owing to the dilution of the bacteriocin.

We describe a simple method for screening bacterial cultures for the production of compounds inhibitory towards other bacteria.

ソフト寒天オーバーレイ技術の使用は、細菌産生阻害する化合物をスクリーニングするために

The soft-agar overlay technique was originally developed over 70 years ago and has been widely used in several areas of microbiological research, ...

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Biofilms are aggregates of microorganisms that rely on a self-produced matrix of extracellular polymeric substance for protection and structural integrity. The nosocomial pathogen, Pseudomonas aeruginosa, is known to adopt a biofilm mode of growth, causing chronic pulmonary infection in patients with cystic fibrosis (CF). The computer program, COMSTAT, is a useful tool for quantifying antimicrobial-induced changes in P. aeruginosa biofilm architecture by extracting data from three-dimensional confocal images. However, standardized operation of the software is less commonly addressed, which is important for optimal reporting of biofilm behavior and cross-center comparison. Thus, the aim of this protocol is to provide a simple and reproducible framework for quantifying in vitro biofilm structures under varying antimicrobial conditions via COMSTAT. The technique is modeled using a CF P. aeruginosa isolate, grown in the form of biofilm replicates, and exposed to tobramycin and the anti-Psl monoclonal antibody, Psl0096. The step-by-step approach aims to reduce user ambiguity and minimize the chance of overlooking crucial image-processing steps. Specifically, the protocol emphasizes the elimination of subjective variations associated with the manual operation of COMSTAT, including image segmentation and the selection of appropriate quantitative analysis functions. Although this method requires users to spend additional time processing confocal images prior to running COMSTAT, it helps minimize misrepresented biofilm heterogenicity in automated outputs.

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Antimicrobial-induced changes to Pseudomonas aeruginosa biofilm architecture differ among clinical isolates cultured from patients with cystic fibrosis and chronic pulmonary infection. Following confocal microscopy, COMSTAT software can be utilized to quantify variations in biofilm architecture (e.g., surface area, thickness, biomass) for individual isolates to assess the efficacy of anti-infective agents.

COMSTATソフトウェアを使用した In vitro バイオフィルムアーキテクチャに対する抗菌剤の影響の定量化

Biofilms are aggregates of microorganisms that rely on a self-produced matrix of extracellular polymeric substance for protection and structural ...

Generation of Greater Bacterial Biofilm Biomass using PCR-Plate Deep Well Microplate Devices

Bacterial biofilms are difficult to eradicate from surfaces using conventional antimicrobial interventions. High-throughput 96-well microplate methods are frequently used to cultivate bacterial biofilms for rapid antimicrobial susceptibility testing to calculate minimal biofilm eradication concentration (MBEC) values. Standard biofilm devices consist of polystyrene pegged-lids fitted to 96-well microplates and are ideal for measuring biofilm biomass and MBEC values, but these devices are limited by available peg surface area for biomass accumulation and cost. Here, we outline a protocol to use self-assembled polypropylene 96-well deep well PCR-plate pegged-lid device to grow Escherichia coli BW25113 and Pseudomonas aeruginosa PAO1 biofilms. A comparison of 24-hour biofilms formed on standard and deep well devices by each species using crystal violet biomass staining and MBEC determination assays are described. The larger surface area of deep well devices expectedly increased overall biofilm formation by both species 2-4-fold. P. aeruginosa formed significantly greater biomass/mm2 on deep well pegs as compared to the standard device. E. coli had greater biomass/mm2 on standard polystyrene devices as compared the deep well device. Biofilm eradication assays with disinfectants such as sodium hypochlorite (bleach) or benzalkonium chloride (BZK) showed that both compounds could eliminate E. coli and P. aeruginosa biofilms from both devices but at different MBEC values. BZK biofilm eradication resulted in variable E. coli MBEC values between devices, however, bleach demonstrated reproducible MBEC values for both species and devices. This study provides a high throughput deep well method for growing larger quantities of biofilms on polypropylene devices for downstream studies requiring higher amounts of static biofilm.

This protocol presents methodology to perform biofilm growth and biomass measurements using self-assembled deep well PCR-plate devices for high-throughput 96-well pegged lid static biofilm screening.

PCRプレートディープウェルマイクロプレートデバイスを用いた細菌バイオフィルムバイオマスの生成

Bacterial biofilms are difficult to eradicate from surfaces using conventional antimicrobial interventions. High-throughput 96-well microplate methods are ...

Evaluation of the Efficacy of Organic Peroxyacids for Eradicating Dairy Biofilms Using an Approach Combining Static and Dynamic Methods

The presence of biofilms in the dairy industry is of major concern, as they may lead to the production of unsafe and altered dairy products due to their high resistance to most clean-in-place (CIP) procedures frequently used in processing plants. Therefore, it is imperative to develop new biofilm control strategies for the dairy industry. This protocol is aimed at evaluating the efficacy of organic peroxyacids (peracetic, perpropionic, and perlactic acids and a commercial peracetic acid-based disinfectant) for eradicating dairy biofilms using a combination of static and dynamic methods. All the disinfectants were tested on the strongest biofilm-producing bacteria in either a single or a mixed biofilm using the minimum biofilm eradication concentration (MBEC) assay, a static high-throughput screening method. A contact time of 5 min with the disinfectants at the recommended concentrations successfully eradicated both the single and mixed biofilms. Studies are currently ongoing to confirm these observations using the Center for Disease Control (CDC) biofilm reactor, a dynamic method to mimic in situ conditions. This type of bioreactor enables the use of a stainless-steel surface, which constitutes most industrial equipment and surfaces. The preliminary results from the reactor appear to confirm the efficacy of organic peroxyacids against biofilms. The combined approach described in this study may be used to develop and test new biological or chemical formulations for controlling biofilms and eradicating microorganisms.

This protocol describes an approach combining static and dynamic methods to evaluate the efficacy of organic peroxyacids for eradicating biofilms in the dairy industry. This approach may also be used to test the effectiveness of new biological or chemical formulations for controlling biofilms.

静的法と動的法を組み合わせたアプローチによる有機ペルオキシ酸の乳バイオフィルム根絶効果評価

The presence of biofilms in the dairy industry is of major concern, as they may lead to the production of unsafe and altered dairy products due to their ...

生物学

<meta charset="utf8"></head><body>クオラムセンシング阻害におけるチオフェネススルホンアミドの生物学的評価

Synthesis and Assay of Vibrio Quorum Sensing Inhibitors

Bacteria detect local population numbers using quorum sensing, a method of cell-cell communication broadly utilized to control bacterial behaviors. In Vibrio species, the master quorum sensing regulators LuxR/HapR control hundreds of quorum sensing genes, many of which influence virulence, metabolism, motility, and more. Thiophenesulfonamides are potent inhibitors of LuxR/HapR that bind the ligand pocket in these transcription factors and block downstream quorum sensing gene expression. This class of compounds served as the basis for the development of a set of simple, robust, and educational procedures for college students to assimilate their chemistry and biology skills using a CURE model: course-based undergraduate research experience. Optimized protocols are described that comprise three learning stages in an iterative and multi-disciplinary platform to engage students in a year-long CURE: (1) design and synthesize new small molecule inhibitors based on the thiophenesulfonamide core, (2) use structural modeling to predict binding affinity to the target, and (3) assay the compounds for efficacy in microbiological assays against specific Vibrio LuxR/HapR proteins. The described reporter assay performed in E. coli successfully predicts the efficacy of the compounds against target proteins in the native Vibrio species.

<meta charset="utf8"></head><body>著者スポットライト:ヒトおよび水生生物のビブリオーシスを治療するための治療法の進歩

Thiophenesulfonamide compounds are potent and specific inhibitors of Vibrio quorum sensing regulators LuxR/HapR that block their activity in vivo, thus preventing transcription of genes for virulence, motility, and biofilms. This protocol details how these compounds are synthesized, modeled in silico, and assayed in vivo for activity against LuxR/HapR.

ビブリオクォーラムセンシング阻害剤の合成とアッセイ

Bacteria detect local population numbers using quorum sensing, a method of cell-cell communication broadly utilized to control bacterial behaviors. In ...

エンジニアクォーラム焼入れラクトナーゼを使用して、病原性バイオフィルムの抗病原性破壊

要約

さらに動画を探す

この動画の章